881 results on '"Barnes, Edward L."'
Search Results
2. Self-Efficacy, Patient Activation, and the Burden of Inflammatory Bowel Disease on Patients’ Daily Lives
3. What’s UP with Ulcerative Proctitis?: It’s Not Always What You Think
4. The Management of Postoperative Recurrence in Crohn’s Disease
5. Antibiotic Use in the 12 Months Prior to Ileal Pouch-Anal Anastomosis Increases the Risk for Pouchitis
6. Acute Kidney Injury in Inflammatory Bowel Disease Patients: A Nationwide Comparative Analysis
7. Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn’s Disease
8. Very Early Pouchitis Is Associated with an Increased Likelihood of Chronic Inflammatory Conditions of the Pouch
9. Lower Extremity Palpable Purpura in a Patient with Quiescent Inflammatory Bowel Disease
10. Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn’s Disease
11. Comparative Effectiveness of Upadacitinib vs Ustekinumab for Ulcerative Colitis: A Multicenter Retrospective Cohort Study
12. AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders
13. Extraintestinal Manifestations and Family History of Inflammatory Bowel Disease Increase the Risk of Pouchitis in a State-Level Epidemiology Study
14. Development of an Inflammatory Bowel Disease-Specific Medication Adherence Instrument and Reasons for Non-adherence
15. Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study
16. Development of the Endoscopic Pouch Score for Assessment of Inflammatory Conditions of the Pouch
17. An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis
18. Disease Monitoring of the Ileoanal Pouch: How to Utilize Biomarkers, Imaging, and Pouchoscopy
19. Relationship Between Stages of Ileal Pouch-Anal Anastomosis, Timing of Restoration of Fecal Continuity, and Pouchitis
20. Off the Cuff Markers: Surveillance and Endoscopic Approaches for Dysplasia After Ileal Pouch-Anal Anastomosis
21. Quality of Care in the Management of Hospitalized Patients with Inflammatory Bowel Disease
22. Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease
23. Patient Reported Outcome Assessments Used in the Evaluation of Patients after Ileal Pouch-Anal Anastomosis: A Systematic Review
24. Increasing Incidence of Pouchitis Between 1996 and 2018: A Population-Based Danish Cohort Study
25. Patients With Pouchitis Demonstrate a Significant Cost Burden in the First Two Years After Ileal Pouch-Anal Anastomosis
26. Test Characteristics of Cross-sectional Imaging and Concordance With Endoscopy in Postoperative Crohn’s Disease
27. Predictors and Outcomes of Ustekinumab Dose Intensification in Ulcerative Colitis: A Multicenter Cohort Study
28. The Natural History After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Population-Based Cohort Study From the United States.
29. Treating IBD? Don’t Forget that Mental Health Matters
30. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021
31. Postoperative Use of Biologics Was Less Common Among Patients With Crohn’s Disease With Emergent/Urgent vs Elective Intestinal Resection
32. Single-Cell Analysis Reveals Unexpected Cellular Changes and Transposon Expression Signatures in the Colonic Epithelium of Treatment-Naïve Adult Crohn’s Disease Patients
33. Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD
34. Diagnosis of Inflammatory Bowel Disease–Associated Peripheral Arthritis: A Systematic Review
35. Reply to Dai, Huang, and Jiang
36. Endoscopic assessment of the J pouch in ulcerative colitis: A narrative review
37. Efficacy and safety of liraglutide in patients with patients with an ileal pouch-anal anastomosis and chronic high bowel frequency: A placebo-controlled, crossover, proof of concept study
38. One-Year Comparative Effectiveness of Upadacitinib vs Tofacitinib for Ulcerative Colitis: A Multicenter Cohort Study
39. Personalized Best: Toward Improving Care in Ulcerative Colitis
40. Incidence, Risk Factors, and Outcomes of Pouchitis and Pouch-Related Complications in Patients With Ulcerative Colitis
41. Development and Validation of a Symptom Based Scoring System for Bowel Dysfunction after Ileoanal Pouch Reconstruction: The Ileoanal Pouch Syndrome Severity Score
42. Creation of a Case-Finding Definition for Identifying Patients With Acute Pouchitis in Administrative Claims Data
43. Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data
44. Same Day Infusion of Iron Therapy Is Associated With No Increased Risk for Adverse Events Among Patients Receiving Biological Infusions for Inflammatory Bowel Disease
45. Quality of Care in the Management of Hospitalized Patients with Inflammatory Bowel Disease
46. Efficacy and Safety of Liraglutide in Patients With an Ileal Pouch-Anal Anastomosis and Chronic High Bowel Frequency: A Placebo-Controlled, Crossover, Proof-of-Concept Study.
47. Change in Biologic Class Promotes Endoscopic Remission Following Endoscopic Postoperative Crohn's Disease Recurrence.
48. Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus.
49. Extensive Colitis and Smoking Are Associated With Postoperative Complications Within 30 Days of Ileal Pouch–Anal Anastomosis.
50. A Practical Guide to the Use of Upadacitinib in Ulcerative Colitis and Crohn's Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.